Tanja Fetter

Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment.

Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: August 01, 2025

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

Journal: Frontiers in immunology

Published: June 16, 2025

Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.

Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.

Journal: Frontiers in immunology

Published: November 22, 2023

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case report.

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case report.

Journal: Frontiers in immunology

Published: October 19, 2023

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.

Journal: American journal of clinical dermatology

Published: March 21, 2023

Aberrant inflammasome activation as a driving force of human autoimmune skin disease.

Aberrant inflammasome activation as a driving force of human autoimmune skin disease.

Journal: Frontiers in immunology

Published: March 20, 2023

Dermatomyositis autoantigen CHD4 forms immune stimulatory complexes with endogenous DNA.

Dermatomyositis autoantigen CHD4 forms immune stimulatory complexes with endogenous DNA.

Journal: Experimental dermatology

Published: August 09, 2022

Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus.

Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus.

Journal: Frontiers in medicine

Published: April 08, 2022

Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model-implications for therapy.

Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model-implications for therapy.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 30, 2021

Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.

Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.

Journal: Cells

Published: November 01, 2020

Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an In Vitro Model.

Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an In Vitro Model.

Journal: Frontiers in immunology

Published: October 28, 2020

Cutaneous lupus erythematosus: The impact of self-amplifying innate and adaptive immune responses and future prospects of targeted therapies.

Cutaneous lupus erythematosus: The impact of self-amplifying innate and adaptive immune responses and future prospects of targeted therapies.

Journal: Experimental dermatology

Published: May 28, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026